These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32552951)

  • 21. Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.
    Aukema SM; Hoster E; Rosenwald A; Canoni D; Delfau-Larue MH; Rymkiewicz G; Thorns C; Hartmann S; Kluin-Nelemans H; Hermine O; Dreyling M; Klapper W
    Blood; 2018 Jan; 131(4):417-420. PubMed ID: 29196411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
    Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
    [No Abstract]   [Full Text] [Related]  

  • 24. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
    Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.
    Dong HJ; Zhou LT; Fang C; Fan L; Zhu DX; Wang YH; Li JY; Xu W
    Med Oncol; 2012 Sep; 29(3):2166-73. PubMed ID: 22057359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
    Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of Body Mass Index on the Prognosis of Mantle Cell Lymphoma].
    Zhang SX; Xie YH; Weng P; Xu SJ; Tian HY; Guo JR; Liu TB; Shen JZ; Li XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1757-1765. PubMed ID: 36476900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas].
    Wu Y; Wang H; Liu XJ; Wang YY; Zhao WL; Li JM; Shen ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1036-1041. PubMed ID: 28823264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical features, therapeutic effects and prognosis of mantle cell lymphoma].
    Zhang HX; Xu J; Liu T; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):231-5. PubMed ID: 21569704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and Clinical Significance of CXCR3 in Mantle Cell Lymphoma].
    Zhu MX; Wan WL; Hong Y; Zhu XW; Hu K; Wan W; Jing HM; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1831-1837. PubMed ID: 31839046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
    Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical features and prognostic analysis of mantle cell lymphoma].
    Bao WY; Wang Y; Hu XM; Li JM; Shen ZX; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):814-8. PubMed ID: 23384900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.
    Räty R; Franssila K; Joensuu H; Teerenhovi L; Elonen E
    Eur J Haematol; 2002 Jul; 69(1):11-20. PubMed ID: 12270057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoldering mantle cell lymphoma.
    Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
    J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
    Asaad NY; Abd El-Wahed MM; Dawoud MM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [PLK1 Expression in Mantle Cell Lymphoma and Its Clinical Significance].
    Shen LY; Lin CM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):833-838. PubMed ID: 31204940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of MiR101 and EZH2 in Patients with Mantle Cell Lymphoma and Its Clinical Significance].
    Lin YL; Zou ZK; Su HY; Huang YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):820-826. PubMed ID: 31204938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.